BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 2, 2005
View Archived Issues
Amylin Scores Again: FDA Clears Byetta In Diabetes
FDA approvals are becoming routine for Amylin Pharmaceuticals Inc., which just received the agency's blessing for the second time in less than two months. (BioWorld Today)
Read More
Advanced Life Sciences IPO: $86.25M To Boost Antibiotic
Read More
Lower IPO Valuations Quashing Early VC Biotechnology Funding
Read More
Ikaria Aiming To 'Buy Time' Via Reversible Hibernation
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More